Atlas Trials

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Clinical trial NCT00390234 · COMPLETED

Trial details

NCT number
NCT00390234
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fallopian Tube CancerFemale Reproductive CancerOvarian CarcinosarcomaOvarian SarcomaRecurrent Ovarian Epithelial CancerRecurrent Uterine SarcomaStage III Ovarian Epithelial CancerStage III Uterine SarcomaStage IV Ovarian Epithelial CancerStage IV Uterine SarcomaUterine CarcinosarcomaUterine Leiomyosarcoma
Start date
2006-09-01
Primary completion
2011-09-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.